Storia in 4 fonti

Indiase kankerpatiënten kampen met tekort medicijnen door prijsstijging platina

Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige fabrikanten hebben de productie verlaagd of zelfs stopgezet.

Raccontata daeconomictimes.indiatimes.comnu.nlthehindubusinessline.comnewsbytesapp.com

Confronto fonti

4 prospettive sulla stessa storia

AI · summaries

nu.nlStai leggendo6 g fa

Indiase kankerpatiënten kampen met tekort medicijnen door prijsstijging platina

Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige fabrikanten hebben de productie verlaagd…

originale

economictimes.indiatimes.com7 g fa

Indian cancer patients battle shortage of key drugs as platinum costs surge

Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces patients to search extensively for medication.…

Leggi questa versione → originale

newsbytesapp.com4 g fa

India hikes cancer drug prices by 50% amid shortages

India's NPPA approved a 50% price hike for carboplatin and cisplatin, citing rising platinum costs, to address accessibility concerns for these critical anti-cancer medicines.

Leggi questa versione → originale

thehindubusinessline.com4 g fa

Cancer: NPPA raises price cap on key drugs amid shortage

NPPA raised ceiling prices for cisplatin and carboplatin 50% as South Africa platinum shortages halted production. For supply chain teams: material scarcity cascades into drug production halts, exposing healthcare operations to geopolitical dependency risk.

Leggi questa versione → originale

Timeline cronologica

1. martedì 9 giugno 2026·economictimes.indiatimes.com
   

   Indian cancer patients battle shortage of key drugs as platinum costs surge

   Cancer patients in India are struggling to find essential platinum-based drugs. A surge in global platinum prices and supply chain issues are causing shortages. This forces…

2. martedì 9 giugno 2026·nu.nl
   

   Indiase kankerpatiënten kampen met tekort medicijnen door prijsstijging platina

   Kankerpatiënten in India hebben grote moeite essentiële geneesmiddelen op basis van platina te vinden. Dat komt door problemen met levering en de sterk gestegen prijzen. Sommige…

3. martedì 9 giugno 2026·thehindubusinessline.com
   

   Cancer patients battle shortage of key drugs as platinum costs surge

   Cancer patients in India face a severe shortage of platinum-based drugs due to rising costs and supply disruptions.

4. mercoledì 10 giugno 2026·economictimes.indiatimes.com
   

   Government may lift price cap on cancer drugs making them costlier by up to 50%

   India's government is taking emergency steps to ensure cancer patients get vital drugs. Cisplatin and carboplatin, crucial chemotherapy agents, faced shortages due to rising raw…

5. venerdì 12 giugno 2026·economictimes.indiatimes.com
   

   India raises price cap on cancer drugs to tackle shortage

   India's drug price regulator has increased the ceiling prices of cancer drugs cisplatin and carboplatin by 50% to tackle shortages caused by a sharp rise in platinum costs. The…

6. venerdì 12 giugno 2026·thehindubusinessline.com
   

   Cancer: NPPA raises price cap on key drugs amid shortage

   India raises price caps on key cancer drugs by 50% to address shortages caused by rising raw material costs.

7. venerdì 12 giugno 2026·newsbytesapp.com
   

   India hikes cancer drug prices by 50% amid shortages

   India's NPPA approved a 50% price hike for carboplatin and cisplatin, citing rising platinum costs, to address accessibility concerns for these critical anti-cancer medicines.